Shares of Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $5.8930, but opened at $6.35. Oxford BioMedica shares last traded at $6.38, with a volume of 6,600 shares traded.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised Oxford BioMedica to a “hold” rating in a research report on Wednesday, July 22nd. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has a consensus rating of “Hold”.
Check Out Our Latest Report on OXBDF
Oxford BioMedica Price Performance
About Oxford BioMedica
Oxford BioMedica plc is a United Kingdom-based contract development and manufacturing organization (CDMO) focused on cell and gene therapies. The company helps biotechnology and pharmaceutical customers develop, test, and manufacture advanced therapies, with expertise in viral-vector technologies used to deliver genetic material into cells.
Its services include process and analytical development, clinical and commercial manufacturing, quality testing, regulatory support, and related research services.
Read More
- Five stocks we like better than Oxford BioMedica
- Analysts See Double-Digit Upside for These 3 Stocks
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
